Mesalazine didn’t help diarrhea-predominant IBS

CHICAGO – Treating diarrhea-predominant irritable bowel syndrome with mesalazine for 12 weeks failed to improve stool frequency or other symptoms, compared with placebo, in a multicenter, randomized...

Field of Interest: Gastroentero...
Type: News Item

Statins linked to lower physical activity

Initiating statin therapy in older men was associated with a modest but significant drop in physical activity, according findings from a large, observational study published online June 9 in JAMA...

Field of Interest: Gastroentero...
Type: News Item

Copaxone lipoatrophy far more common than reported

DALLAS – The risk of lipoatrophy with glatiramer acetate is greater than 60%, according to a review of 73 multiple sclerosis patients at one clinic. The risk is "substantially higher than...

Field of Interest: Dermatology
Type: News Item

Azathioprine, anti-TNF monotherapy safe in IBD pregnancy

CHICAGO – Women with inflammatory bowel disease can safely continue monotherapy with azathioprine/6-mercaptopurine or antitumor necrosis–alpha agents during pregnancy to maintain remission, according...

Field of Interest: Pulmonology
Type: News Item

Atopic dermatitis update taps top therapy choices

WAIKOLOA, HAWAII – The 2014 update of the American Academy of Dermatology guidelines on atopic dermatitis take a strong stance in favor of the use of topical calcineurin inhibitors as topical...

Field of Interest: Dermatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.